Armodafinil waklert 150 consists of armodafinil 150 mg that serves as a wakefulness-promoting agent.
In Australia, armodafinil is prescribed for excessive sleepiness in cases of narcolepsy, obstructive sleep apnoea/hypopnoea syndrome (OSAHS), and chronic shift work sleep disorder (SWSD). In relation to OSAHS, armodafinil is applied for the management of daytime sleepiness symptom and should be used concomitantly with appropriate treatment, including CPAP therapy, but not addressing airway obstruction.
As to the 150 mg strength, this dose is especially important from the perspective of the following approved dosage regimens. According to the Australian product information, the doses include 150 mg or 250 mg once daily in the morning in case of narcolepsy and OSAHS and 150 mg of armodafinil for SWSD (approximately one hour before work shift). Armodafinil is available in oral tablet form and is a Schedule 4 prescription medicine in Australia. Thus, all these details indicate that Waklert 150 is a medication designed for maintaining wakefulness in particular cases.
https://www.genericmedsaustralia.com.au/products/waklert-150-australia/
